← All trials
NCT00441415
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2007
- Primary completion
- Oct 1, 2007
- Completion date
- Oct 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 272
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- GaldermaLead sponsor
- Helendale Dermatology, Rochester, NYOfficial
- Technical University of DresdenOfficial
- University of LubeckOfficial
- University of KielOfficial
- J. W. Goethe UniversityOfficial
- Otto von Guericke UniversityOverall official - principal investigator
- Academic Dermatology Associates - Albuquerque NMOfficial
- Minnesota Clinical Study CenterOfficial
- Clinical Research Specialists, Inc.Official
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.